Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Two recent developments limiting antibiotic use could have a secondary benefit of reducing <em>Clostridium difficile</em> infections, which have been the bane of infection preventionists since emerging in a highly virulent strain some 15 years ago. </p>

Antibiotic Use Reductions May Decrease Clostridium difficile

FDA warning on fluoroquinolones, IDSA says limit therapy for VAP